Generics BulletinDr Reddy’s and Alvotech have struck a further biosimilars alliance, announcing today a co-development partnership for a rival to Merck & Co/Merck Sharp & Dohme’s top-selling Keytruda (pembroli
ScripPublicly traded biopharmaceutical companies have faced a rough year for fundraising in 2025 with the amount of money raised across all financing types down significantly from 2024 levels during the
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Will Try Camurus’s FluidCrystal D
Generics BulletinAlvotech and Advanz have swelled their already considerable biosimilars partnership, striking a fresh agreement for a further three product candidates in Europe, including two for rare diseases. The n